Coding
Trial Use
May change in future releases. See Maturity Model.
Computational Definition
A structured representation of a code for a defined concept in a terminology or code system.
Information Model
Some Coding attributes are inherited from Element.
Field |
Flags |
Type |
Limits |
Description |
|---|---|---|---|---|
id |
string |
0..1 |
The ‘logical’ identifier of the data element in the system of record, e.g. a UUID. This ‘id’ is unique within a given system, but may or may not be globally unique outside the system. It is used within a system to reference an object from another. |
|
extensions |
⋮ | 0..m |
A list of extensions to the Entity, that allow for capture of information not directly supported by elements defined in the model. |
|
name |
string |
0..1 |
The human-readable name for the coded concept, as defined by the code system. |
|
system |
string |
1..1 |
The terminology/code system that defined the code. May be reported as a free-text name (e.g. ‘Sequence Ontology’), but it is preferable to provide a uri/url for the system. |
|
systemVersion |
string |
0..1 |
Version of the terminology or code system that provided the code. |
|
code |
1..1 |
A symbol uniquely identifying the concept, as in a syntax defined by the code system. e.g. ‘civic.did:30’, ‘MONDO:005061’, and ‘C3512’ are codes defined by different systems for representing the concept of ‘lung adenocarcinoma’. If a dereferencable identifier is available for the code, it should be provided in the iris field. |
||
iris |
⋮ | 0..m |
A list of IRIs that are associated with the coding. This can be used to provide additional context or to link to additional information about the concept. |
Inherits: Element
Used in: Variant Amp/Asco/Cap Evidence Line (AAC 2017), Concept Mapping, Mappable Concept, Variant Clinical Significance Statement (AAC 2017), Variant Oncogenicity Evidence Line (CCV 2022), Variant Oncogenicity Statement (CCV 2022), Variant Pathogenicity Evidence Line (ACMG 2015), Variant Pathogenicity Statement (ACMG 2015)